NAPOS Database

Acute Porphyria Drugs

A16AX03 - Sodium Phenylbutyrate
Propably not porphyrinogenic
PNP
Rationale
Sodium phenylbutyrate does not affect the activity of cytochrome P450 enzymes.
Metabolism and pharmacokinetics
Similar drugs
Explore alternative drugs in similar therapeutic classes A16A / A16AX or go back.
References
Tradenames
Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps Pheburane Ammonaps · Pheburane · Sodium phenylbutyrate Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Pheburane Pheburane Ammonaps Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane Ammonaps · Pheburane
In cooperation with Ipnet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙